Decreased Cerebrospinal Fluid Orexin-A (Hypocretin-1) Concentrations in Patients after Generalized Convulsive Status Epilepticus.

biomarker cerebrospinal fluid generalized convulsive status epilepticus hypocretin 1 orexin-A

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
19 Oct 2020
Historique:
received: 10 09 2020
revised: 10 10 2020
accepted: 13 10 2020
entrez: 22 10 2020
pubmed: 23 10 2020
medline: 23 10 2020
Statut: epublish

Résumé

The effects of status epilepticus on the orexin/hypocretin system have yet to be investigated. The present study aimed to assay orexin-A/hypocretin-1 in the cerebrospinal fluid (CSF) of patients after generalized convulsive status epilepticus (GCSE). The study groups included 20 GCSE patients, 24 patients diagnosed with epilepsy but remaining in remission (ER), and 25 normal controls (CTR). Diagnostic lumbar puncture was performed in GCSE patients within 3-10 days of seizure cessation, as well as in the ER and to CTR subjects. Among all GCSE patients, the outcome was graded according to the modified Rankin Scale (mRS) at 1-month follow-up. Orexin-A levels were measured in unextracted CSF samples, using a commercial radioimmunoassay. There was a significant overall difference in median CSF orexin-A concentrations between GCSE, RE, and CTR patients (

Identifiants

pubmed: 33086714
pii: jcm9103354
doi: 10.3390/jcm9103354
pmc: PMC7589455
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Science Center in Poland
ID : UMO-2011/01/M/NZ4/04916

Références

Epilepsia. 2015 Oct;56(10):1515-23
pubmed: 26336950
Pharmacol Biochem Behav. 2015 Mar;130:77-83
pubmed: 25600753
Neurology. 2001 Dec 26;57(12):2253-8
pubmed: 11756606
Neurol Sci. 2014 Feb;35(2):245-52
pubmed: 23852314
Neurol Neurochir Pol. 2018 Aug;52(4):419-426
pubmed: 29937151
Epilepsia. 2009 Jun;50(6):1641-4
pubmed: 19175390
Life Sci. 2016 Apr 1;150:81-8
pubmed: 26916826
Brain Res. 1999 Mar 13;821(2):526-9
pubmed: 10064841
Sleep. 2017 Mar 01;40(3):
pubmed: 28364414
Anesth Analg. 2007 Feb;104(2):338-40
pubmed: 17242090
Curr Opin Neurobiol. 2011 Dec;21(6):897-903
pubmed: 21963829
Peptides. 2012 Apr;34(2):419-22
pubmed: 22394654
Neuroscience. 2003;121(4):855-63
pubmed: 14580935
J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):597-8
pubmed: 15774458
BMC Neurosci. 2018 Aug 13;19(1):49
pubmed: 30103703
Arch Neurol. 2002 Oct;59(10):1553-62
pubmed: 12374492
Stroke. 1988 Dec;19(12):1497-500
pubmed: 3201508
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10911-6
pubmed: 10485925
Lancet Neurol. 2015 Jun;14(6):615-24
pubmed: 25908090
Brain Res. 2006 Sep 13;1109(1):164-75
pubmed: 16904080
Neuroscience. 2004;127(2):519-28
pubmed: 15262340

Auteurs

Mojdeh Samzadeh (M)

Department of Neurology, Medical University of Lublin, 20-954 Lublin, Poland.

Ewa Papuć (E)

Department of Neurology, Medical University of Lublin, 20-954 Lublin, Poland.

Marzena Furtak-Niczyporuk (M)

Department of Public Health, Medical University of Lublin, 20-954 Lublin, Poland.

Konrad Rejdak (K)

Department of Neurology, Medical University of Lublin, 20-954 Lublin, Poland.

Classifications MeSH